Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Neuropsychiatric Disease and Treatment|May 20, 2022
Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and SchizophreniaLarry Culpepper, Eduard Vieta, Deanna L Kelly, et al.
Alternative Therapies in Health and Medicine|December 1, 2009
Yoga for chronic low back pain in a predominantly minority population: a pilot randomized controlled trialRobert B Saper, Karen J Sherman, Diana Cullum-Dugan, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|July 16, 2004
Suicidality as a Possible Side Effect of Antidepressant TreatmentLarry Culpepper, Jonathan R. T. Davidson, Allen J. Dietrich, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|July 17, 2007
Characteristics and course of panic disorder and panic disorder with agoraphobia in primary care patientsJennifer L Francis, Risa B Weisberg, Ingrid R Dyck, et al.
The Journal of Nervous and Mental Disease|February 11, 2004
Chronicity in posttraumatic stress disorder and predictors of the course of posttraumatic stress disorder among primary care patientsCaron Zlotnick, Benjamin F Rodriguez, Risa B Weisberg, et al.
The Journal of Nervous and Mental Disease|February 16, 2006
Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patientsBenjamin F Rodriguez, Risa B Weisberg, Maria E Pagano, et al.
Annals of Family Medicine|March 10, 2010
Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary careBradley N Gaynes, Joanne DeVeaugh-Geiss, Sam Weir, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|November 3, 2009
The Joint Admission Medical Program: a statewide approach to expanding medical education and career opportunities for disadvantaged studentsBernell Dalley, Alan Podawiltz, Robert Castro, et al.
Neuropsychopharmacology Reports|December 4, 2024
Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptomsAndrew Krystal, Pierre Blier, Larry Culpepper, et al.
Contemporary Clinical Trials|September 8, 2015
Design and rationale for a randomized controlled trial to reduce readmissions among patients with depressive symptomsSuzanne E Mitchell, Jessica M Martin, Katherine Krizman, et al.
Pageof 13